Automated Cell Culture Systems Market - Growth Trends & Forecasts (2025 - 2030)

The Automated Cell Culture Systems Market Report is Segmented by Product (Cell Culture Process Automation Instrument, Automated Bioreactor, Automated Cell Culture Media Exchange System, Automated Culture Media Analyzer, Automated Cell Counter, and Other Products), Cell Culture Types (Finite Cell Line Cultures and Infinite Cell Line Cultures), Application (Cancer Research, Drug Development, Stem Cell Research, Regenerative Medicine, and Cell Therapy), End User (Pharmaceutical Companies, Biotechnology Companies, CDMOs/CMOs, Research Organizations and Academic Institutes, and Hospitals (Providing Cell Therapy/Regenerative Medicine)) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (In USD) for the Above Segments.

Automated Cell Culture Systems Market - Growth Trends & Forecasts (2025 - 2030)

Automated Cell Culture Systems Market Size

Automated Cell Culture Systems Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 14.27 Billion
Market Size (2030) USD 21.27 Billion
CAGR (2025 - 2030) 8.32 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Automated Cell Culture Systems Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Automated Cell Culture Systems Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Automated Cell Culture Systems Market Analysis

The Automated Cell Culture Systems Market size is estimated at USD 14.27 billion in 2025, and is expected to reach USD 21.27 billion by 2030, at a CAGR of 8.32% during the forecast period (2025-2030).

The automated cell culture systems market is a dynamic and rapidly evolving sector within the life sciences and biotechnology industries. This market is influenced by the rise in the demand for biopharmaceuticals, advancements in cell-based research, and the need for precise, reproducible, and high-throughput cell culture processes. These systems offer enhanced productivity, reduced contamination risks, and improved data management, making them indispensable in applications ranging from drug discovery and vaccine production to regenerative medicine and personalized therapies. With ongoing technological innovations and a growing emphasis on automation in research and production, the automated cell culture systems market is poised for continued growth and innovation.

Chronic conditions are on the rise, including cancer, diabetes, and autoimmune diseases. Automated cell culture systems play a crucial role in drug discovery and development to address these health challenges. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) data published in December 2022, approximately six in ten Americans have at least one chronic disease. This signifies a high prevalence of chronic diseases, which significantly impacts research and developments in biopharmaceuticals.

Apart from this, the report released by the World Health Organization (WHO) in September 2023 points to the fact that around 41 million people die each year due to a chronic illness, which includes cardiovascular disorders followed by cancer and other chronic illnesses. This number projects a high number of treatment cases around the world, which would eventually impact the market’s growth. Biopharmaceuticals are required due to the rising burden of chronic diseases in the world, which is driving this market's expansion.

Apart from this, ongoing advancements in cell-based research, including regenerative medicine, tissue engineering, and personalized medicine, require precise and controlled cell culture conditions, which automated systems can provide. Factors such as collaboration for introducing new technologies in regenerative medicines and launching new systems further propel the market's growth.

For instance, Sony Group Corporation launched a new Cell Isolation System, CGX10, in December 2022. This device facilitates rapid cell sorting and can be used in studies to create cell-based products for industries like cell therapy and regenerative medicine. Also, for instance, in March 2023, Canon Inc. acquired assets of Kyoto Seisakusho Co. Ltd, which included the technology for mass production of cells for use in regenerative medicines and other clinical applications. These instances point out the growth of the market due to the advancements in this field of interest.

Therefore, the market is expected to grow during the forecast period due to factors such as the increased demand for biopharmaceuticals, rising incidence of chronic diseases, and advancements in cell-based research. However, factors such as high investment costs for the automated cell culture systems and regulatory compliance challenges act as restraining parameters for the market's growth.

Automated Cell Culture Systems Industry Overview

The automated cell culture systems market is competitive. Market players invest significantly in R&D to develop advanced automated cell culture systems that offer improved functionality, ease of use, scalability, and compatibility with a wide range of cell types. Continuous innovation is crucial to stay competitive and meet the changing requirements of users. Some market players are Danaher (Beckman Coulter, Inc., Cytiva), Thermo Fisher Scientific Inc., Hitachi Ltd, Becton, Dickinson and Company (BD), and Sartorius AG.

Automated Cell Culture Systems Market Leaders

  1. Danaher (Beckman Coulter, Inc., Cytiva)

  2. Thermo Fisher Scientific Inc.

  3. Hitachi, Ltd.

  4. Becton, Dickinson and Company (BD)

  5. Sartorius AG

  6. *Disclaimer: Major Players sorted in no particular order
Automated Cell Culture Systems Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Automated Cell Culture Systems Market News

• In February 2023, Thermo Fisher Scientific Inc. formed a strategic collaboration with Celltrio, a leading manufacturer of robotics-based products in the life sciences sector. The focus of this collaboration was to introduce a cutting-edge, fully automated cell culture system tailored for biotherapeutics customers. This initiative aimed to meet the growing demand for high-throughput automated cell line culturing and maintenance.

• In May 2022, Cytiva inaugurated a state-of-the-art facility recognized as the Center of Excellence for cell and gene therapies. The products manufactured at this facility are destined for use in regulatory-approved therapies and clinical trials, showcasing Cytiva's commitment to advancing innovations in the field.

Automated Cell Culture Systems Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Demand for Biopharmaceuticals and Rising Incidence of Chronic Diseases
    • 4.2.2 Rise in the Research Funding in Life Sciences Research and Advancements in Cell-Based Research
  • 4.3 Market Restraints
    • 4.3.1 High Investment Costs for the Automated Cell Culture Systems
    • 4.3.2 Regulatory Compliance Challenges
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Cell Culture Process Automation Instrument
    • 5.1.2 Automated Bioreactor
    • 5.1.3 Automated Cell Culture Media Exchange System
    • 5.1.4 Automated Culture Media Analyzer
    • 5.1.5 Automated Cell Counter
    • 5.1.6 Other Products
  • 5.2 By Cell Culture Type
    • 5.2.1 Finite Cell Line Cultures
    • 5.2.2 Infinite Cell Line Cultures
  • 5.3 By Application
    • 5.3.1 Cancer Research
    • 5.3.2 Drug Development
    • 5.3.3 Stem Cell Research
    • 5.3.4 Regenerative Medicine
    • 5.3.5 Cell Therapy
  • 5.4 By End-User
    • 5.4.1 Pharmaceutical Companies
    • 5.4.2 Biotechnology Companies
    • 5.4.3 CDMOs/CMOs
    • 5.4.4 Research Organizations and Academic Institutes
    • 5.4.5 Hospitals (Providing Cell Therapy/Regenerative Medicine)
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danaher (Beckman Coulter, Inc., Cytiva)
    • 6.1.2 Thermo Fisher Scientific Inc
    • 6.1.3 Hitachi, Ltd
    • 6.1.4 Becton, Dickinson and Company (BD)
    • 6.1.5 Sartorius AG
    • 6.1.6 PerkinElmer Inc. (Nexcelom Bioscience LLC.)
    • 6.1.7 Merck KGaA
    • 6.1.8 F. Hoffmann-La Roche Ltd
    • 6.1.9 Agilent Technologies, Inc.
    • 6.1.10 Hamilton Company
    • 6.1.11 Corning Incorporated
    • 6.1.12 Shimadzu Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Automated Cell Culture Systems Industry Segmentation

Automated cell culture systems are specialized laboratory equipment and setups designed to automate the process of growing and maintaining cell cultures.

The automated cell culture systems market is segmented into products, cell culture types, applications, end users, and geography. The market is segmented by product into cell culture process automation instruments, automated bioreactors, automated cell culture media exchange systems, automated culture media analyzers, automated cell counters, and others. By cell culture types, the market is segmented into finite cell line cultures and infinite cell line cultures. The market is segmented by application into cancer research, drug development, stem cell research, regenerative medicine, and cell therapy. By end user, the market is segmented into pharmaceutical companies, biotechnology companies, CDMOs/CMOs, research organizations, academic institutes, and hospitals providing cell therapy/regenerative medicine. The market is segmented by geography into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report offers the value (USD) for the above segments.

By Product Cell Culture Process Automation Instrument
Automated Bioreactor
Automated Cell Culture Media Exchange System
Automated Culture Media Analyzer
Automated Cell Counter
Other Products
By Cell Culture Type Finite Cell Line Cultures
Infinite Cell Line Cultures
By Application Cancer Research
Drug Development
Stem Cell Research
Regenerative Medicine
Cell Therapy
By End-User Pharmaceutical Companies
Biotechnology Companies
CDMOs/CMOs
Research Organizations and Academic Institutes
Hospitals (Providing Cell Therapy/Regenerative Medicine)
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Automated Cell Culture Systems Market Research FAQs

How big is the Automated Cell Culture Systems Market?

The Automated Cell Culture Systems Market size is expected to reach USD 14.27 billion in 2025 and grow at a CAGR of 8.32% to reach USD 21.27 billion by 2030.

What is the current Automated Cell Culture Systems Market size?

In 2025, the Automated Cell Culture Systems Market size is expected to reach USD 14.27 billion.

Who are the key players in Automated Cell Culture Systems Market?

Danaher (Beckman Coulter, Inc., Cytiva), Thermo Fisher Scientific Inc., Hitachi, Ltd., Becton, Dickinson and Company (BD) and Sartorius AG are the major companies operating in the Automated Cell Culture Systems Market.

Which is the fastest growing region in Automated Cell Culture Systems Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Automated Cell Culture Systems Market?

In 2025, the North America accounts for the largest market share in Automated Cell Culture Systems Market.

What years does this Automated Cell Culture Systems Market cover, and what was the market size in 2024?

In 2024, the Automated Cell Culture Systems Market size was estimated at USD 13.08 billion. The report covers the Automated Cell Culture Systems Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Automated Cell Culture Systems Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Automated Cell Culture Systems Industry Report

Statistics for the 2025 Automated Cell Culture Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Automated Cell Culture Systems analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.